Drugs, direct purchase costs break the ceiling of more than 1900 million

Rome, April 14 – Aifa has made available the documents on the monthly monitoring of national and regional pharmaceutical expenditure for the period January / November 2021carried out on the basis of the agreed expenditure data and the summary accounting statements (Dcr) obtained by the Regions, as well as the data obtained from the new National Information System (NIS) of the Ministry of Health, on the traceability of the drug (Ministerial Decree July 15, 2004).